Related Experiment Videos

High-dose systemic iron chelation attenuates reperfusion injury

B E Hedlund¹, P E Hallaway

¹Biomedical Frontiers, Inc., Minneapolis, MN 55414.

Biochemical Society Transactions

|May 1, 1993

Summary

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

First human studies with a high-molecular-weight iron chelator.

The Journal of laboratory and clinical medicine·2000

The long-acting parenteral iron chelator, hydroxyethyl starch-deferoxamine, fails to protect against alcohol-induced liver injury in rats.

The Journal of pharmacology and experimental therapeutics·1997

Assessment of microvascular integrity in the isolated perfused rat liver by contrast-enhanced MRI. Attenuation of reperfusion injury by conjugated deferoxamine.

Magnetic resonance in medicine·1996

Iron deprivation increases erythropoietin production in vitro, in normal subjects and patients with malignancy.

British journal of haematology·1996

Protective effects of hydroxyethyl starch-deferoxamine in early sepsis.

Shock (Augusta, Ga.)·1995

Extracellular iron chelators protect kidney cells from hypoxia/reoxygenation.

Free radical biology & medicine·1994

See all related articles